Drugs / Al(OH)3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00717834 | Jun → Oct 2008 | Ross river fever | Alachua Government Services, Inc. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT05901636 Background | May 2023 → Aug 2024 | — | Janssen Vaccines & Prevention B.V. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Al(OH)3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00717834 ↗ |
| Route | Intramuscular | “Al(OH)3 will be administered intramuscularly.” NCT05901636 ↗ |